Reflect Scientific launches dual-mode ultra-low freezer
Reflect Scientific Inc. (RSCF) launched the PF-90 Blast Plate Freezer, a dual-mode ultra-low freezer for biopharmaceuticals and vaccines. The device operates between -40°C and -90°C, with a 20-year warranty. The company cites a growing market for blast freezers, estimated at $1.84B in 2025, and a biomedical refrigerator and freezer market at $4.34B in 2025.
How this was made
The 30-second read
Why it matters
The PF‑90 launch adds a dual‑mode freezer to its portfolio, targeting high‑value biopharma clients. No financial terms disclosed.
Market read
Product launch is a modest catalyst for a micro‑cap; limited immediate trading relevance.
What to watch
Potential for future FDA‑related validation and partnership announcements could amplify impact.
Background
Reflect Scientific (RSCF) is a small U.S. company providing cryogenic storage solutions for the life‑sciences sector.
Ticker impact
Reflect Scientific announced the launch of its dual‑mode PF‑90 Blast Plate Freezer, a new product for biopharma storage.
likely modest pressure as market prices in the product announcement
Micro‑cap with limited scale; launch adds capability but no large contract disclosed.
Market effects
Highlights ongoing innovation in biopharma cold‑chain equipment, may spur interest in related suppliers.
U.S. biotech equipment niche; limited broader regional effect.
Minor, confined to specialized biotech storage market.
Counterpoint
Without a confirmed large customer or contract, the launch may not translate into near‑term revenue.
Key entities
- companyReflect Scientific Inc.
U.S. provider of cryogenic storage equipment.
